Last reviewed · How we verify
Charitable Union for the Research and Education of Peyronie's Disease — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Control - Crossover to CCH | Control - Crossover to CCH | marketed | Collagenase enzyme | Collagen (types I and III) | Urology / Sexual Medicine | |
| CCH administration | CCH administration | marketed | Collagenase enzyme | Collagen I and III | Urology / Sexual Health |
Therapeutic area mix
- Urology / Sexual Health · 1
- Urology / Sexual Medicine · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- DMR Research, PLLC · 1 shared drug class
- Hospital for Special Surgery, New York · 1 shared drug class
- Indiana Hand to Shoulder Center · 1 shared drug class
- Luxurgery · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Charitable Union for the Research and Education of Peyronie's Disease:
- Charitable Union for the Research and Education of Peyronie's Disease pipeline updates — RSS
- Charitable Union for the Research and Education of Peyronie's Disease pipeline updates — Atom
- Charitable Union for the Research and Education of Peyronie's Disease pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Charitable Union for the Research and Education of Peyronie's Disease — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/charitable-union-for-the-research-and-education-of-peyronie-s-disease. Accessed 2026-05-17.